Concepedia
Statistics
Publications
21
Citations
623
H-Index
16
Active since
2009
Affiliations
Nanchang University(Current)
Second Affiliated Hospital of Nanchang University
University of Electronic Science and Technology of China
First Affiliated Hospital of Nanchang University
Université Paris Cité
Honglin Hu is an author at Nanchang University specializing in medicine, pharmacology, and renal ischemia.
Publications per year
2009–2024
MicroRNA-21 Attenuates Renal Ischemia Reperfusion Injury via Targeting Caspase Signaling in Mice
Honglin Hu, Wei Jiang, Xiaoqing Xi et al. · American Journal of Nephrology · 2014 · 61 citations
Life Sciences, Molecular Biology, Pathobiology +17
FAT10 promotes the progression of bladder cancer by upregulating HK2 through the EGFR/AKT pathway
Yan Zou, Yunyan Du, Cheng Cheng et al. · Experimental Cell Research · 2020 · 53 citations
Medicine, Oncology, Urology +13
Pioglitazone protects tubular cells against hypoxia/reoxygenation injury through enhancing autophagy via AMPK-mTOR signaling pathway
Xiaoqing Xi, Cong Zou, Zhenfeng Ye et al. · European Journal of Pharmacology · 2019 · 47 citations
Life Sciences, Cell Biology, Pharmacology +14
Pioglitazone protects against renal ischemia-reperfusion injury by enhancing antioxidant capacity
Cong Zou, Honglin Hu, Xiaoqing Xi et al. · Journal of Surgical Research · 2013 · 45 citations
Medicine, Nephrology, Pharmacology +16
Pioglitazone Protects Against Renal Ischemia-Reperfusion Injury via the AMP-Activated Protein Kinase-Regulated Autophagy Pathway
Wenlin Chen, Xiaoqing Xi, Shuangyang Zhang et al. · Frontiers in Pharmacology · 2018 · 44 citations · Full text
Life Sciences, Molecular Biology, Pharmacology +17
1–5 of 21